Health Care & Life Sciences » Biotechnology | HedgePath Pharmaceuticals Inc.

HedgePath Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
SG&A Expense
1,882.50
3,937.80
3,949.60
7,022.20
5,119.00
4,564.30
EBIT
1,882.50
3,937.80
3,949.60
7,022.20
5,119.00
4,564.30
Unusual Expense
49.40
-
-
-
-
-
Interest Expense
1.90
37.50
-
-
-
-
Pretax Income
1,835.10
3,975.30
3,949.60
7,000.20
5,101.20
4,550.20
Consolidated Net Income
1,835.10
3,975.30
3,949.60
7,000.20
5,101.20
4,550.20
Net Income
1,835.10
3,975.30
3,949.60
7,000.20
5,101.20
4,550.20
Net Income After Extraordinaries
1,835.10
3,975.30
3,949.60
7,000.20
5,101.20
4,550.20
Net Income Available to Common
1,835.10
3,975.30
3,949.60
7,000.20
5,101.20
4,706.70
EPS (Basic)
0.10
0.04
0.02
0.02
0.01
0.01
Basic Shares Outstanding
17,940.60
95,884.50
232,616.60
288,752.70
366,622.10
369,812.90
EPS (Diluted)
0.10
0.04
0.02
0.02
0.01
0.01
Diluted Shares Outstanding
17,940.60
95,884.50
232,616.60
288,752.70
366,622.10
369,812.90
EBITDA
1,882.50
3,937.80
3,949.60
7,022.20
5,119.00
-
Non-Operating Interest Income
-
-
-
22.00
17.90
14

About HedgePath Pharmaceuticals

View Profile
Address
4830 West Kennedy Boulevard
Tampa Florida 33609
United States
Employees -
Website http://www.hedgepathpharma.com
Updated 07/08/2019
HedgePath Pharmaceuticals, Inc. is clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. It also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.